Hepatoblastoma is the most common malignant liver tumor in the pediatric population but treatment strategies have changed dramatically over the past couple of decades so today we will review the basics of hepatoblastoma with Dr. Greg Tiao, MD – pediatric transplant surgeon at Cincinnati Children’s Hospital Medical Center.

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial
https://pubmed.ncbi.nlm.nih.gov/30975630/

The paediatric hepatic international tumour trial (PHITT): clinical trial design in rare disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660185/